TrialInternational journal of hematology2017

Safety of ASP0113, a cytomegalovirus DNA vaccine, in recipients undergoing allogeneic hematopoietic cell transplantation: an open-label phase 2 trial.

Takehiko Mori et al.PubMed ↗Publisher ↗

No numbers read from the abstract.